1. Home
  2. WEST vs ARVN Comparison

WEST vs ARVN Comparison

Compare WEST & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westrock Coffee Company

WEST

Westrock Coffee Company

HOLD

Current Price

$7.96

Market Cap

773.6M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.05

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEST
ARVN
Founded
2009
2015
Country
United States
United States
Employees
1393
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
773.6M
658.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
WEST
ARVN
Price
$7.96
$8.05
Analyst Decision
Strong Buy
Buy
Analyst Count
2
19
Target Price
$7.00
$15.05
AVG Volume (30 Days)
1.0M
815.8K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
N/A
$262,600,000.00
Revenue This Year
$11.27
N/A
Revenue Next Year
$10.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.59
$6.06
52 Week High
$8.98
$14.22

Technical Indicators

Market Signals
Indicator
WEST
ARVN
Relative Strength Index (RSI) 57.74 27.27
Support Level $7.73 $7.35
Resistance Level $8.98 $8.22
Average True Range (ATR) 0.48 0.43
MACD -0.12 -0.04
Stochastic Oscillator 19.23 0.99

Price Performance

Historical Comparison
WEST
ARVN

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider mainly in the United States. Additionally, it offers coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice, restaurant, convenience store, travel center, non-commercial account, and hospitality industries around the world. The company's reportable segments are: Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment, which offers beverage solutions, including coffee, tea, flavors, extracts, and ingredients. Geographically, the company generates maximum revenue from its business in the United States and the rest from other countries.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: